Search Results - "MIRTSKHULAVA, V"

Introducing BPaL: Experiences from countries supported under the LIFT-TB project by Wares, D. F., Mbenga, M., Mirtskhulava, V., Quelapio, M., Slyzkyi, A., Koppelaar, I., Cho, S. N., Go, U., Lee, J. S., Jung, J.-K., Everitt, D., Foraida, S., Diachenko, M., Juneja, S., Burhan, E., Totkogonova, A., Myint, Z., Flores, I., Lytvynenko, N. A., Parpieva, N., Nhung, N. V., Gebhard, A.

“…Background Previously, drug-resistant tuberculosis (DR-TB) patients were treated with long, toxic, and relatively ineffective regimens. However, in recent…”
Get full text

Risk factors for unfavourable treatment outcomes among rifampicin-resistant tuberculosis patients in Tajikistan by Makhmudova, M., Maxsumova, Z., Rajabzoda, A., Makhmadov, A., van den Hof, S., Mirtskhulava, V.

“…SETTING: Tajikistan is among the 30 countries with the highest multidrug-resistant tuberculosis (MDR-TB) burden.OBJECTIVE: To investigate the risk factors for…”
Get full text

Rates and risk factors for nephrotoxicity and ototoxicity among tuberculosis patients in Tbilisi, Georgia by Buziashvili, M., Mirtskhulava, V., Kipiani, M., Blumberg, H. M., Baliashvili, D., Magee, M. J., Furin, J. J., Tukvadze, N., Kempker, R. R.

“…SETTING: Treatment of multidrug-resistant tuberculosis (MDR-TB) is lengthy and utilizes second-line anti-TB drugs associated with frequent adverse drug…”
Get full text

Experiences in the introduction of bedaquiline pretomanid linezolid for drug-resistant tuberculosis in Kyrgyzstan by Myrzaliev, B., Ahmatov, M., Duishekeeva, A., Kulzhabaeva, A., Kadyrov, A., Toktogonova, A., Abdulaeva, G., Wares, D.F., Mirtskhulava, V., Mbenga, M., Slyzkyi, A., Foraida, S., Diachenko, M., Juneja, S., Turdumambetova, G., Musaeva, A., Gebhard, A.

“…In Kyrgyzstan, drug-resistant tuberculosis poses a significant challenge. Recognizing the potential of the BPaL regimen, the World Health Organization…”
Get full text

Prevalence and risk factors for multidrug-resistant tuberculosis in the Republic of Georgia: a population-based study by LOMTADZE, N, ASPINDZELASHVILI, R, JANJGAVA, M, MIRTSKHULAVA, V, WRIGHT, A, BLUMBERG, H. M, SALAKAIA, A

“…SETTING: Multidrug-resistant tuberculosis (MDR-TB, defined as resistance to at least isoniazid and rifampicin) has emerged as a serious global public health…”
Get full text

Prevalence and risk factors for latent tuberculosis infection among health care workers in Georgia by MIRTSKHULAVA, V, KEMPKER, R, SHIELDS, K. L, LEONARD, M. K, TSERTSVADZE, T, DEL RIO, C, SALAKAIA, A, BLUMBERG, H. M

“…BACKGROUND: Tuberculosis (TB) is a major public health problem in Georgia, but few TB infection control measures have been implemented in health care…”
Get full text

Features of GERD therapy in obese patients: A review by Bakulina, Natalia V., Tikhonov, Sergey V., Efremova, Anastasia Yu, Mirtskhulava, Vakhtang V.

“…Epidemiological, endoscopic and pathophysiological studies confirm the relationship between obesity and gastroesophageal reflux disease (GERD) and is…”
Get full text

Decentralised ECG monitoring for drug-resistant TB patients in ambulatory settings by Mbenga, M., Slyzkyi, A., Mirtskhulava, V., Pak, S., Gebhard, A., Utepkalieva, G., Sagimbekova, A., Adenov, M., Ryskulov, G.

Get full text